Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timed Aspirin for Celecoxib-Induced Blood Pressure Changes
NCT03590821Phase 1Not yet recruiting
- Sponsor
- University of Pennsylvania
- Start
- Dec 2027
- Primary completion
- Jan 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of aspirin in hypertension (HTN) (2 arms), sponsored by University of Pennsylvania. Primary endpoint: Blood pressure. Planned start Dec 2027; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03590821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03590821.